ID   TALDO_HUMAN             Reviewed;         337 AA.
AC   P37837; B2R8M2; O00751; Q8WV32; Q8WZ45;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   15-MAR-2017, entry version 187.
DE   RecName: Full=Transaldolase;
DE            EC=2.2.1.2;
GN   Name=TALDO1; Synonyms=TAL, TALDO, TALDOR;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8300619;
RA   Banki K., Halladay D.L., Perl A.;
RT   "Cloning and expression of the human gene for transaldolase. A novel
RT   highly repetitive element constitutes an integral part of the coding
RT   sequence.";
RL   J. Biol. Chem. 269:2847-2851(1994).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=9339383; DOI=10.1006/geno.1997.4932;
RA   Banki K., Eddy R.L., Shows T.B., Halladay D.L., Bullrich F.,
RA   Croce C.M., Jurecic V., Baldini A., Perl A.;
RT   "The human transaldolase gene (TALDO1) is located on chromosome 11 at
RT   p15.4-p15.5.";
RL   Genomics 45:233-238(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9524206; DOI=10.1016/S0378-1119(97)00639-2;
RA   Kusuda J., Hirai M., Toyoda A., Tanuma R., Nomura-Kitabayashi A.,
RA   Hashimoto K.;
RT   "Cloning and chromosomal localization of a paralog and a mouse homolog
RT   of the human transaldolase gene.";
RL   Gene 209:13-21(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10702296; DOI=10.1074/jbc.275.10.7261;
RA   Perl A., Colombo E., Samoilova E., Butler M.C., Banki K.;
RT   "Human transaldolase-associated repetitive elements are transcribed by
RT   RNA polymerase III.";
RL   J. Biol. Chem. 275:7261-7272(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 33-110.
RA   Perl A.;
RT   "Family of active retrotransposons carry two exons of the
RT   transaldolase gene and shows evidence of reverse splicing in human
RT   DNA.";
RL   Submitted (NOV-2001) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-219; LYS-269; LYS-286 AND
RP   LYS-321, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237 AND SER-256, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-237, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.45 ANGSTROMS), SUBUNIT, AND ACTIVE SITE.
RX   PubMed=10869557; DOI=10.1016/S0014-5793(00)01658-6;
RA   Thorell S., Gergely P. Jr., Banki K., Perl A., Schneider G.;
RT   "The three-dimensional structure of human transaldolase.";
RL   FEBS Lett. 475:205-208(2000).
RN   [13]
RP   VARIANT TALDOD SER-171 DEL.
RX   PubMed=11283793; DOI=10.1086/320108;
RA   Verhoeven N.M., Huck J.H.J., Roos B., Struys E.A., Salomons G.S.,
RA   Douwes A.C., van der Knaap M.S., Jakobs C.;
RT   "Transaldolase deficiency: liver cirrhosis associated with a new
RT   inborn error in the pentose phosphate pathway.";
RL   Am. J. Hum. Genet. 68:1086-1092(2001).
CC   -!- FUNCTION: Transaldolase is important for the balance of
CC       metabolites in the pentose-phosphate pathway.
CC   -!- CATALYTIC ACTIVITY: Sedoheptulose 7-phosphate + D-glyceraldehyde
CC       3-phosphate = D-erythrose 4-phosphate + D-fructose 6-phosphate.
CC   -!- PATHWAY: Carbohydrate degradation; pentose phosphate pathway; D-
CC       glyceraldehyde 3-phosphate and beta-D-fructose 6-phosphate from D-
CC       ribose 5-phosphate and D-xylulose 5-phosphate (non-oxidative
CC       stage): step 2/3.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:10869557}.
CC   -!- INTERACTION:
CC       Q9NYB0:TERF2IP; NbExp=2; IntAct=EBI-1056712, EBI-750109;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}.
CC   -!- DISEASE: Transaldolase deficiency (TALDOD) [MIM:606003]: An inborn
CC       error of the pentose phosphate pathway resulting in early-onset
CC       multisystem disease. Clinical features include growth retardation,
CC       dysmorphic features, cutis laxa, congenital heart disease,
CC       hepatosplenomegaly, telangiectases of the skin, pancytopenia, and
CC       bleeding tendency. {ECO:0000269|PubMed:11283793}. Note=The disease
CC       is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the transaldolase family. Type 1 subfamily.
CC       {ECO:0000305}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L19437; AAB53943.1; -; mRNA.
DR   EMBL; AF010400; AAC52068.1; -; Genomic_DNA.
DR   EMBL; AF010398; AAC52068.1; JOINED; Genomic_DNA.
DR   EMBL; AF010399; AAC52068.1; JOINED; Genomic_DNA.
DR   EMBL; AF058913; AAF40478.1; -; Genomic_DNA.
DR   EMBL; AK313427; BAG36219.1; -; mRNA.
DR   EMBL; BC010103; AAH10103.1; -; mRNA.
DR   EMBL; BC018847; AAH18847.2; -; mRNA.
DR   EMBL; L27346; AAL31313.1; -; Genomic_DNA.
DR   CCDS; CCDS7712.1; -.
DR   PIR; A49985; A49985.
DR   RefSeq; NP_006746.1; NM_006755.1.
DR   UniGene; Hs.438678; -.
DR   PDB; 1F05; X-ray; 2.45 A; A/B=1-337.
DR   PDBsum; 1F05; -.
DR   ProteinModelPortal; P37837; -.
DR   SMR; P37837; -.
DR   BioGrid; 112751; 75.
DR   IntAct; P37837; 10.
DR   MINT; MINT-4999914; -.
DR   STRING; 9606.ENSP00000321259; -.
DR   Allergome; 9551; Hom s Transaldolase.
DR   iPTMnet; P37837; -.
DR   PhosphoSitePlus; P37837; -.
DR   SwissPalm; P37837; -.
DR   BioMuta; TALDO1; -.
DR   DMDM; 6648092; -.
DR   OGP; P37837; -.
DR   REPRODUCTION-2DPAGE; IPI00744692; -.
DR   EPD; P37837; -.
DR   MaxQB; P37837; -.
DR   PaxDb; P37837; -.
DR   PeptideAtlas; P37837; -.
DR   PRIDE; P37837; -.
DR   TopDownProteomics; P37837; -.
DR   Ensembl; ENST00000319006; ENSP00000321259; ENSG00000177156.
DR   GeneID; 6888; -.
DR   KEGG; hsa:6888; -.
DR   UCSC; uc001lqz.4; human.
DR   CTD; 6888; -.
DR   DisGeNET; 6888; -.
DR   GeneCards; TALDO1; -.
DR   HGNC; HGNC:11559; TALDO1.
DR   HPA; HPA040373; -.
DR   HPA; HPA048089; -.
DR   MalaCards; TALDO1; -.
DR   MIM; 602063; gene.
DR   MIM; 606003; phenotype.
DR   neXtProt; NX_P37837; -.
DR   OpenTargets; ENSG00000177156; -.
DR   Orphanet; 101028; Transaldolase deficiency.
DR   PharmGKB; PA36328; -.
DR   eggNOG; KOG2772; Eukaryota.
DR   eggNOG; COG0176; LUCA.
DR   GeneTree; ENSGT00390000017361; -.
DR   HOGENOM; HOG000281234; -.
DR   HOVERGEN; HBG054014; -.
DR   InParanoid; P37837; -.
DR   KO; K00616; -.
DR   OMA; MLNEDQM; -.
DR   OrthoDB; EOG091G0FTU; -.
DR   PhylomeDB; P37837; -.
DR   TreeFam; TF300757; -.
DR   Reactome; R-HSA-163754; Insulin effects increased synthesis of Xylulose-5-Phosphate.
DR   Reactome; R-HSA-71336; Pentose phosphate pathway (hexose monophosphate shunt).
DR   UniPathway; UPA00115; UER00414.
DR   ChiTaRS; TALDO1; human.
DR   EvolutionaryTrace; P37837; -.
DR   GenomeRNAi; 6888; -.
DR   PRO; PR:P37837; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000177156; -.
DR   CleanEx; HS_TALDO1; -.
DR   ExpressionAtlas; P37837; baseline and differential.
DR   Genevisible; P37837; HS.
DR   GO; GO:0005737; C:cytoplasm; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048029; F:monosaccharide binding; IEA:Ensembl.
DR   GO; GO:0004801; F:sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity; EXP:Reactome.
DR   GO; GO:0005975; P:carbohydrate metabolic process; TAS:ProtInc.
DR   GO; GO:0006002; P:fructose 6-phosphate metabolic process; IEA:Ensembl.
DR   GO; GO:0006098; P:pentose-phosphate shunt; TAS:Reactome.
DR   GO; GO:0009052; P:pentose-phosphate shunt, non-oxidative branch; IEA:Ensembl.
DR   GO; GO:0005999; P:xylulose biosynthetic process; TAS:Reactome.
DR   CDD; cd00957; Transaldolase_TalAB; 1.
DR   Gene3D; 3.20.20.70; -; 1.
DR   HAMAP; MF_00492; Transaldolase_1; 1.
DR   InterPro; IPR013785; Aldolase_TIM.
DR   InterPro; IPR001585; TAL/FSA.
DR   InterPro; IPR004730; Transaldolase_1.
DR   InterPro; IPR018225; Transaldolase_AS.
DR   PANTHER; PTHR10683; PTHR10683; 1.
DR   PANTHER; PTHR10683:SF22; PTHR10683:SF22; 1.
DR   Pfam; PF00923; TAL_FSA; 1.
DR   TIGRFAMs; TIGR00874; talAB; 1.
DR   PROSITE; PS01054; TRANSALDOLASE_1; 1.
DR   PROSITE; PS00958; TRANSALDOLASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Complete proteome; Cytoplasm;
KW   Disease mutation; Pentose shunt; Phosphoprotein; Reference proteome;
KW   Schiff base; Transferase.
FT   CHAIN         1    337       Transaldolase.
FT                                /FTId=PRO_0000173564.
FT   ACT_SITE    142    142       Schiff-base intermediate with substrate.
FT                                {ECO:0000269|PubMed:10869557}.
FT   MOD_RES     115    115       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:Q93092}.
FT   MOD_RES     219    219       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     237    237       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     256    256       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   MOD_RES     269    269       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     286    286       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     321    321       N6-acetyllysine.
FT                                {ECO:0000244|PubMed:19608861}.
FT   VARIANT     171    171       Missing (in TALDOD).
FT                                {ECO:0000269|PubMed:11283793}.
FT                                /FTId=VAR_011511.
FT   HELIX        14     21       {ECO:0000244|PDB:1F05}.
FT   STRAND       22     27       {ECO:0000244|PDB:1F05}.
FT   TURN         31     34       {ECO:0000244|PDB:1F05}.
FT   HELIX        35     37       {ECO:0000244|PDB:1F05}.
FT   STRAND       40     43       {ECO:0000244|PDB:1F05}.
FT   HELIX        46     53       {ECO:0000244|PDB:1F05}.
FT   HELIX        56     58       {ECO:0000244|PDB:1F05}.
FT   HELIX        59     72       {ECO:0000244|PDB:1F05}.
FT   HELIX        76     98       {ECO:0000244|PDB:1F05}.
FT   STRAND      103    106       {ECO:0000244|PDB:1F05}.
FT   HELIX       109    111       {ECO:0000244|PDB:1F05}.
FT   HELIX       115    131       {ECO:0000244|PDB:1F05}.
FT   HELIX       136    138       {ECO:0000244|PDB:1F05}.
FT   STRAND      139    144       {ECO:0000244|PDB:1F05}.
FT   HELIX       147    160       {ECO:0000244|PDB:1F05}.
FT   STRAND      164    169       {ECO:0000244|PDB:1F05}.
FT   HELIX       172    180       {ECO:0000244|PDB:1F05}.
FT   STRAND      184    190       {ECO:0000244|PDB:1F05}.
FT   HELIX       191    200       {ECO:0000244|PDB:1F05}.
FT   HELIX       208    210       {ECO:0000244|PDB:1F05}.
FT   HELIX       212    226       {ECO:0000244|PDB:1F05}.
FT   STRAND      232    236       {ECO:0000244|PDB:1F05}.
FT   HELIX       241    245       {ECO:0000244|PDB:1F05}.
FT   TURN        246    249       {ECO:0000244|PDB:1F05}.
FT   STRAND      250    255       {ECO:0000244|PDB:1F05}.
FT   HELIX       257    265       {ECO:0000244|PDB:1F05}.
FT   HELIX       276    281       {ECO:0000244|PDB:1F05}.
FT   HELIX       291    299       {ECO:0000244|PDB:1F05}.
FT   HELIX       302    330       {ECO:0000244|PDB:1F05}.
SQ   SEQUENCE   337 AA;  37540 MW;  8CB4992AEF364E64 CRC64;
     MSSSPVKRQR MESALDQLKQ FTTVVADTGD FHAIDEYKPQ DATTNPSLIL AAAQMPAYQE
     LVEEAIAYGR KLGGSQEDQI KNAIDKLFVL FGAEILKKIP GRVSTEVDAR LSFDKDAMVA
     RARRLIELYK EAGISKDRIL IKLSSTWEGI QAGKELEEQH GIHCNMTLLF SFAQAVACAE
     AGVTLISPFV GRILDWHVAN TDKKSYEPLE DPGVKSVTKI YNYYKKFSYK TIVMGASFRN
     TGEIKALAGC DFLTISPKLL GELLQDNAKL VPVLSAKAAQ ASDLEKIHLD EKSFRWLHNE
     DQMAVEKLSD GIRKFAADAV KLERMLTERM FNAENGK
//
